Search results for "leed"

showing 10 items of 267 documents

Use of rivaroxaban for the prevention of stroke in patients with nonvalvular atrial fibrillation in Spain

2018

Aim: To analyze the clinical profile and rates of stroke, major bleeding and intracranial hemorrhage of patients with atrial fibrillation (AF) treated with rivaroxaban in clinical practice. Methods: Retrospective study of AF patients anticoagulated with rivaroxaban in a Healthcare Area of Valencia, Spain. Patients started treatment with rivaroxaban from July 2012 to December 2015. Results: A total of 230 patients (mean age 76.9 ± 9.9 years; CHA2DS2-VASc 4.3 ± 1.7; HAS-BLED 1.7 ± 0.9) were included. Rates of stroke, major bleeding and intracranial bleeding were 0.4, 1.9 and 0.5 events per 100 patient-years, respectively. Conclusion: In this cohort of AF patients anticoagulated with rivaroxa…

Malemedicine.medical_specialtyHemorrhage030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRivaroxabanRisk FactorsInternal medicineAtrial FibrillationmedicineHumansIn patient030212 general & internal medicinePractice Patterns Physicians'StrokeAgedRetrospective StudiesAged 80 and overRivaroxabanbusiness.industryRetrospective cohort studyMean ageAtrial fibrillationmedicine.diseaseStrokeSpainCohortMolecular MedicineFemaleCardiology and Cardiovascular MedicinebusinessMajor bleedingFactor Xa Inhibitorsmedicine.drugFuture Cardiology
researchProduct

Endoscopic hemostasis followed by preventive transarterial embolization in high-risk patients with bleeding peptic ulcer: 5-year experience

2019

Abstract Background Upper gastrointestinal bleeding (UGIB) due to peptic ulcer disease is one of the leading causes of death in patients with non-variceal bleeding, resulting in up to 10% mortality rate, and the patient group at high risk of rebleeding (Forrest IA, IB, and IIA) often requires additional therapy after endoscopic hemostasis. Preventive transarterial embolization (P-TAE) after endoscopic hemostasis was introduced in our institution in 2014. The aim of the study is an assessment of the intermediate results of P-TAE following primary endoscopic hemostasis in patients with serious comorbid conditions and high risk of rebleeding. Methods During the period from 2014 to 2018, a tota…

Malemedicine.medical_specialtyLeft gastric arteryTransarterial embolizationmedicine.medical_treatmentlcsh:SurgeryNon-variceal gastrointestinal bleeding030230 surgeryGastroduodenal artery03 medical and health sciences0302 clinical medicineRecurrencePreventivemedicine.arterymedicineHumansEmbolizationAgedAged 80 and overbusiness.industryMortality rateHemostasis Endoscopiclcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RD1-811lcsh:RC86-88.9Middle Agedmedicine.diseaseEmbolization TherapeuticSurgeryPeptic Ulcer HemorrhageTreatment OutcomeEmergency MedicineFemale030211 gastroenterology & hepatologySurgeryFresh frozen plasmaUpper gastrointestinal bleedingPacked red blood cellsRockall scorebusinessResearch ArticleWorld Journal of Emergency Surgery
researchProduct

Clinical indicators of periodontal disease in patients with coronary heart disease : a 10 years longitudinal study

2011

Objectives: There is evidence about a possible relationship existing between periodontal diseases and coronary heart disease. The aim of the present longitudinal study was to investigate the changes in periodontal evolution after etiological periodontal treatment, comparing a healthy control group with another having coronary heart disease. Study Design: The study included initially 55 patients of which 44 finished it. They were placed into two groups: Healthy Control Group (HCG) n =9, and Coronary Heart Disease Group (CHDG) n=35. The gingival level (GL), probing depth (PD), clinical attachment level (CAL), plaque index (PI) and bleeding on probing (BOP) were measured to compare the periodo…

Malemedicine.medical_specialtyLongitudinal studyTime FactorsPlaque indexBleeding on probingDentistryCoronary DiseaseGastroenterologyPeriodontal diseaseInternal medicinemedicineHumansIn patientLongitudinal StudiesPeriodontal IndicesGeneral DentistryPeriodontal Diseasesbusiness.industry:CIENCIAS MÉDICAS [UNESCO]Coronary heart diseaseOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASEtiologyFemaleResearch-ArticleOdontostomatology for the Disabled or Special PatientsSurgeryPeriodontal Indexmedicine.symptombusiness
researchProduct

Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for …

2009

The optimal management of bleeding or its prophylaxis in patients with disorders of platelet count or function is controversial. The bleeding diathesis of these patients is usually mild to moderate: therefore, transfusion of platelet concentrates may be inappropriate, as potential adverse effects might outweigh its benefit. The availability of several anti-hemorrhagic drugs further compounds this problem, mainly because the efficacy/suitability of the various treatment options in different clinical manifestations is not well defined. In these guidelines, promoted by the Italian Society for Studies on Haemostasis and Thrombosis (Società Italiana per lo Studio dell'Emostasi e della Trombosi […

Malemedicine.medical_specialtyPlatelet disorderMEDLINESettore MED/15 - Malattie Del Sangueplatelet transfusionmedicineHumansPlateletAprotininIntensive care medicineAdverse effectDesmopressinbusiness.industrySettore MED/09 - MEDICINA INTERNAHematologybleedingmedicine.diseaseThrombosisThrombocytopeniaSurgeryBleeding diathesisItalySurgical Procedures Operativeplatelet defectsFemaleBlood Platelet Disordersbusinessmedicine.drugThrombosis research
researchProduct

Assessment of cerebral microbleeds by susceptibility-weighted imaging at 3T in patients with end-stage organ failure

2018

Purpose: Cerebral microbleeds (CMBs) are small rounded lesions representing cerebral hemosiderin deposits surrounded by macrophages that results from previous microhemorrhages. The aim of this study was to review the distribution of cerebral microbleeds in patients with end-stage organ failure and their association with specific end-stage organ failure risk factors. Materials and methods: Between August 2015 and June 2017, we evaluated 15 patients, 9 males, and 6 females, (mean age 65.5 years). Patients population was subdivided into three groups according to the organ failure: (a) chronic kidney failure (n = 8), (b) restrictive cardiomyopathy undergoing heart transplantation (n = 1), and (…

Malemedicine.medical_specialtyRadiology Nuclear Medicine and Imagingmedicine.medical_treatmentPopulationLiver transplantationOrgan transplantation030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineMagnetic resonance imagingRisk FactorsmedicineHumanseducationNeuroradiologyAgedCerebral HemorrhageHeart transplantationeducation.field_of_studyCardiomyopathy RestrictiveTransplantationbusiness.industryCerebral microbleedGeneral MedicineSusceptibility-weighted imagingEnd-stage organ failureLiver TransplantationTransplantationCerebral microbleeds; End-stage organ failure; Magnetic resonance imaging; Susceptibility-weighted imaging; Transplantation; Radiology Nuclear Medicine and ImagingHemosiderinSusceptibility weighted imagingHeart TransplantationKidney Failure ChronicFemaleRadiologybusiness030217 neurology & neurosurgeryLiver Failure
researchProduct

Aspirin treatment improves bladder function after outlet obstruction in rabbits.

2001

Abstract Objectives. To examine whether bladder smooth muscle dysfunction after outlet obstruction could be altered by treatment with aspirin. Long-term outlet obstruction causes contractile and metabolic dysfunction of the bladder in vivo and in vitro. The evidence is growing that a decrease in bladder perfusion is an important cause of this phenomenon. The platelet aggregation inhibitor, acetylsalicylic acid (aspirin), has been used to improve perfusion of the heart for decades. Methods. Ten male New Zealand white rabbits were obstructed for 4 weeks. Five rabbits received no further treatment (Obs), and 5 rabbits received 2 mg/kg/day aspirin (Obs+aspirin), administered by an osmotic pump …

Malemedicine.medical_specialtyUrologyInjections SubcutaneousUrinary BladderUrologyConnective tissueStimulationurologic and male genital diseasesBladder outlet obstructionBleeding timeInternal medicinemedicineAnimalsDrug ImplantsAspirinmedicine.diagnostic_testAspirinbusiness.industryMuscle SmoothOrgan SizeUrinary Bladder Neck ObstructionNeck of urinary bladderEndocrinologymedicine.anatomical_structurePlatelet aggregation inhibitorRabbitsbusinessPerfusionmedicine.drugUrology
researchProduct

Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report.

2006

Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report. Pirrello R, Siragusa S, Giambona C, D'Arpa S, Cordova A, Moschella F. Source Dipartimento di Discipline Chirurgiche ed Oncologiche, Sezione di Chirurgia Plastica e Ricostruttiva, Università di Palermo, Palermo, Italy. Abstract The association between factor VII deficiency and cleft palate has never been described. The case of a child with cleft palate and factor VII deficiency who successfully underwent palatoplasty is described in this article. To allow surgical treatment, through maintenance of a normal prothrombin time, the patient was given 15 microg/kg of recombinant factor VIIa every 12 hours, …

Malemedicine.medical_specialtymedicine.medical_treatmentFactor VII DeficiencyPremedicationBlood Loss SurgicalFactor VIIaPostoperative HemorrhageEfficacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMedicineHumans030223 otorhinolaryngologyFactor VII deficiencyProthrombin timemedicine.diagnostic_testFactor VIIbiologybusiness.industryCoagulantsPalate030206 dentistryPerioperativePlastic Surgery ProceduresRecombinant ProteinsSurgeryCleft PalatePalatoplastyEl NiñochemistryOtorhinolaryngologyRecombinant factor VIIaAnesthesiaChild Preschoolbiology.proteinFACTOR VII DEFICIENCY CLEFT PALATE BLEEDING PROPHYLAXISProthrombin TimeOral SurgerybusinessThe Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
researchProduct

A rare complication of ERCP: Mallory-Weiss syndrome

2005

OBJECTIVE: To describe the management and outcome after endoscopic treatment of hematemesis by Mallory-Weiss Syndrome (MWS) occurred after CPRE (suspected choledocolithiasis). Background data: Although cough and retching is common during EGD or CPRE, MWS resulting from endoscopy seems to be uncommon (0.0001-0.04%) and always self-limiting. Case report: The patient was submitted to CPRE with the suspicion of choledocholithiasis. Eight hours after CPRE the patient presented with hematemesis amd hypotension. With emergency EGD, the AA identified a small bleeding mucosal tear (visible vessel with spurting) just proximal to the esophagogastric junction. The patient was safely treated with endosc…

Mallory-Weiss Syndromegastrointestinal bleedingHemorrhage
researchProduct

Association between marfan syndrome and oral health status : a systematic review and meta-analysis

2019

Background: The purpose was to identify and assess the existing scientific evidence from epidemiologic, non-experimental, observational studies of associations between Marfan’s syndrome and oral diseases. Material and Methods: Electronic literature searches in MEDLINE (OVID), The Cochrane Library, Scopus and the Web of Science were conducted to identify all relevant articles. Eligibility was based on inclusion criteria, and quality assessments were conducted. The outcome variables were probing depth, gingival margin, clinical attachment level, bleeding on probing, gingival status, periodontal status, tooth mobility, furcation involvement and decayed, missing and filled teeth index. After ex…

Marfan syndromemedicine.medical_specialtyCàries dentalCross-sectional studyBleeding on probingMEDLINEOral HealthMalalties periodontalsReviewCochrane LibraryMarfan SyndromeTooth mobility03 medical and health sciences0302 clinical medicineOral hygieneInternal medicinemedicineHumansGeneral Dentistrybusiness.industryConnective tissues diseases030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMedically compromised patients in DentistryHigiene bucalCross-Sectional StudiesOtorhinolaryngologyMeta-analysisUNESCO::CIENCIAS MÉDICASDental cariesSurgeryMalalties del teixit connectiumedicine.symptomPeriodontal diseasebusinessGingival margin
researchProduct

Emergency sclerotherapy or band ligation combined with vasoactive drugs for bleeding esophageal varices in cirrhosis

2019

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy as well as adverse events of emergency sclerotherapy (or band ligation) combined with pharmacological treatments versus sclerotherapy (or band ligation) alone or vasoactive drugs alone for acute variceal bleeding in cirrhotic patients based on the results of randomised clinical trials (RCTs).

Medicine General & Introductory Medical Sciencesmedicine.medical_specialtyCirrhosisbusiness.industrymedicine.medical_treatmentmedicine.diseaseGastroenterologySurgeryInternal medicineVasoactivemedicineBleeding esophageal varicesSclerotherapyPharmacology (medical)LigationbusinessCochrane Database of Systematic Reviews
researchProduct